Livzon Pharmaceutical Group Inc. (SHE:000513)
China flag China · Delayed Price · Currency is CNY
34.53
+0.38 (1.11%)
Apr 8, 2026, 3:04 PM CST

SHE:000513 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Operating Revenue
11,89711,70112,32612,52411,928
Other Revenue
123.46111.73104.45105.89135.88
12,02011,81212,43012,63012,064
Revenue Growth (YoY)
1.76%-4.97%-1.58%4.69%14.67%
Cost of Revenue
4,1354,2494,7724,5774,309
Gross Profit
7,8857,5647,6588,0537,754
Selling, General & Admin
4,1823,8694,2554,5454,548
Research & Development
937.951,0331,3351,4271,146
Other Operating Expenses
139.71120.33133.07143.97135.87
Operating Expenses
5,2595,0275,7366,1215,837
Operating Income
2,6272,5361,9211,9321,917
Interest Expense
-57.21-88.61-102.09-97.55-84
Interest & Investment Income
347.65265.34429.98359.25251.81
Currency Exchange Gain (Loss)
-22.920.9410.2356.68-4.28
Other Non Operating Income (Expenses)
-5.72-6.98-4.42-6.37-4.01
EBT Excluding Unusual Items
2,8882,7072,2552,2442,077
Gain (Loss) on Sale of Investments
17.98-15.44-25.65-75.27-23.03
Gain (Loss) on Sale of Assets
-0.5445.2-0.170.867.03
Asset Writedown
-73.35-19.86-2.43-13.99-6.15
Other Unusual Items
29.4989.08155.76174.68191.12
Pretax Income
2,8622,8062,3832,3312,246
Income Tax Expense
451.01501.66485.07374.97293.59
Earnings From Continuing Operations
2,4112,3041,8981,9561,952
Minority Interest in Earnings
-387.79-243.3956.05-46.17-176.42
Net Income
2,0232,0611,9541,9091,776
Net Income to Common
2,0232,0611,9541,9091,776
Net Income Growth
-1.84%5.50%2.32%7.53%3.54%
Shares Outstanding (Basic)
893920929935935
Shares Outstanding (Diluted)
893920931936936
Shares Change (YoY)
-2.96%-1.10%-0.56%-0.04%-0.25%
EPS (Basic)
2.272.242.102.041.90
EPS (Diluted)
2.272.242.102.041.90
EPS Growth
1.16%6.64%2.94%7.47%3.73%
Free Cash Flow
2,5712,4092,4281,833593.23
Free Cash Flow Per Share
2.882.622.611.960.63
Dividend Per Share
1.4301.1001.3501.6001.300
Dividend Growth
30.00%-18.52%-15.63%23.08%4.00%
Gross Margin
65.60%64.03%61.61%63.76%64.28%
Operating Margin
21.85%21.47%15.46%15.30%15.89%
Profit Margin
16.83%17.45%15.72%15.12%14.72%
Free Cash Flow Margin
21.39%20.39%19.54%14.51%4.92%
EBITDA
3,1733,0922,7402,5632,342
EBITDA Margin
26.40%26.18%22.05%20.29%19.41%
D&A For EBITDA
546.04555.85818.8630.56425.02
EBIT
2,6272,5361,9211,9321,917
EBIT Margin
21.85%21.47%15.46%15.30%15.89%
Effective Tax Rate
15.76%17.88%20.36%16.09%13.07%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.